肝移植后的巨细胞病毒感染
Cytomegalovirus infection after liver transplantation.
作者信息
Lizaola-Mayo Blanca C, Rodriguez Eduardo A
机构信息
Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ 85259, United States.
Division of Gastroenterology, Hepatology & Nutrition, University of Utah, Salt Lake City, UT 84132, United States.
出版信息
World J Transplant. 2020 Jul 29;10(7):183-190. doi: 10.5500/wjt.v10.i7.183.
Abstract
Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver transplant recipients. CMV infections in post liver transplant patients cause significant morbidity and mortality, directly affecting post-transplant outcomes. This review will provide the framework for the surveillance, diagnosis, prophylaxis and treatment of CMV in the liver transplant population.
摘要
人巨细胞病毒（CMV）是肝移植受者中最常见的机会性感染。肝移植术后患者的CMV感染会导致显著的发病率和死亡率，直接影响移植后的预后。本综述将为肝移植人群中CMV的监测、诊断、预防和治疗提供框架。
相似文献
1
Cytomegalovirus infection after liver transplantation.肝移植后的巨细胞病毒感染
World J Transplant. 2020 Jul 29;10(7):183-190. doi: 10.5500/wjt.v10.i7.183.
2
Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.移植前巨细胞病毒免疫球蛋白G抗体水平可预防肝移植受者移植后发生严重巨细胞病毒感染：来自一家三级医疗肝脏中心的经验。
Indian J Med Microbiol. 2017 Oct-Dec;35(4):499-503. doi: 10.4103/ijmm.IJMM_17_201.
3
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.巨细胞病毒作为原位肝移植受者侵袭性真菌病危险因素的独立作用。波士顿肝移植中心CMVIG研究组。赛美维，MedImmune公司，马里兰州盖瑟斯堡。
Am J Med. 1997 Aug;103(2):106-13. doi: 10.1016/s0002-9343(97)80021-6.
4
Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.无类固醇免疫抑制的胰腺移植中巨细胞病毒的发生率及预后
Clin Transplant. 2015 Dec;29(12):1221-9. doi: 10.1111/ctr.12655. Epub 2015 Nov 20.
5
Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.供体和受体巨细胞病毒血清学对肺移植受者长期生存的影响。
Transpl Infect Dis. 2018 Oct;20(5):e12964. doi: 10.1111/tid.12964. Epub 2018 Jul 20.
6
Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.活体供肝移植受者的巨细胞病毒感染对移植后早期结局有显著影响：单中心经验
Transpl Infect Dis. 2018 Aug;20(4):e12905. doi: 10.1111/tid.12905. Epub 2018 May 24.
7
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.供体和受体巨细胞病毒血清学对心脏移植受者长期生存的影响。
Transpl Infect Dis. 2019 Feb;21(1):e13015. doi: 10.1111/tid.13015. Epub 2018 Nov 19.
8
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.荟萃分析：巨细胞病毒预防实体器官移植受者器官疾病策略的疗效
Ann Intern Med. 2005 Dec 20;143(12):870-80. doi: 10.7326/0003-4819-143-12-200512200-00005.
9
High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.尽管进行了预防性治疗，实体器官移植后仍存在巨细胞病毒感染的高风险。
J Med Virol. 2013 May;85(5):893-8. doi: 10.1002/jmv.23539.
引用本文的文献
1
Side Effects of Immunosuppressant Drugs After Liver Transplant.肝移植后免疫抑制药物的副作用
Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342.
2
The Association Between Cytomegalovirus Infection and Kidney Damage in the Liver Transplant Setting.肝移植环境中巨细胞病毒感染与肾损伤之间的关联。
Viruses. 2024 Nov 26;16(12):1830. doi: 10.3390/v16121830.
3
Management of cytomegalovirus infection after liver transplantation.肝移植术后巨细胞病毒感染的管理
World J Transplant. 2024 Sep 18;14(3):93209. doi: 10.5500/wjt.v14.i3.93209.
4
An Elastin-like Polypeptide-fusion peptide targeting capsid-tegument interface as an antiviral against cytomegalovirus infection.一种靶向衣壳-被膜界面的弹性蛋白样多肽融合肽作为抗巨细胞病毒感染的抗病毒药物。
Sci Rep. 2024 May 4;14(1):10253. doi: 10.1038/s41598-024-60691-6.
5
Cytomegalovirus Duodenitis Causing Persistent Hypoalbuminemia and Ascites After Liver Transplantation.肝移植后巨细胞病毒性十二指肠炎症致持续性低白蛋白血症和腹水
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101387. doi: 10.1016/j.jceh.2024.101387. Epub 2024 Feb 24.
6
Algorithmic Approach to Deranged Liver Functions After Transplantation.移植后肝功能紊乱的算法处理方法
J Clin Exp Hepatol. 2024 May-Jun;14(3):101317. doi: 10.1016/j.jceh.2023.101317. Epub 2023 Dec 12.
7
Infections After Liver Transplant -Timeline, Management and Prevention.肝移植后的感染——时间线、管理与预防
J Clin Exp Hepatol. 2024 May-Jun;14(3):101316. doi: 10.1016/j.jceh.2023.101316. Epub 2023 Dec 14.
8
Guillain-Barré syndrome following primary cytomegalovirus infection in a patient with liver transplantation.肝移植术后巨细胞病毒原发性感染致格林-巴利综合征。
BMJ Case Rep. 2024 Jan 4;17(1):e255739. doi: 10.1136/bcr-2023-255739.
9
Vitamin D status as a predictor for liver transplant outcomes.维生素 D 状态作为肝移植结局的预测因子。
Sci Rep. 2023 Nov 29;13(1):21018. doi: 10.1038/s41598-023-48496-5.
10
Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients.巨细胞病毒特异性 T 细胞在儿科肝移植受者中的作用。
Viruses. 2023 Nov 4;15(11):2213. doi: 10.3390/v15112213.
本文引用的文献
1
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者巨细胞病毒感染：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13512. doi: 10.1111/ctr.13512. Epub 2019 Mar 28.
2
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.估算全球巨细胞病毒的血清流行率：系统综述和荟萃分析。
Rev Med Virol. 2019 May;29(3):e2034. doi: 10.1002/rmv.2034. Epub 2019 Jan 31.
3
Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review.肝移植后巨细胞病毒病——一例治疗抵抗病例的描述：病例报告及文献综述
Transplant Proc. 2018 Dec;50(10):4015-4022. doi: 10.1016/j.transproceed.2018.05.014. Epub 2018 May 29.
4
Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.人巨细胞病毒潜伏和再激活的分子决定因素与调控。
Viruses. 2018 Aug 20;10(8):444. doi: 10.3390/v10080444.
5
Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients.实体器官移植受者巨细胞病毒感染与 CMV 特异性 CD8+ T 细胞免疫功能评分和淋巴细胞亚群的临床相关性。
Transplantation. 2019 Apr;103(4):832-838. doi: 10.1097/TP.0000000000002396.
6
New Developments in the Management of Cytomegalovirus Infection After Transplantation.移植后巨细胞病毒感染管理的新进展。
Drugs. 2018 Jul;78(11):1085-1103. doi: 10.1007/s40265-018-0943-1.
7
Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.定期监测中危肾移植受者巨细胞病毒特异性细胞介导免疫：移植后即刻评估的预测价值。
Clin Microbiol Infect. 2019 Mar;25(3):381.e1-381.e10. doi: 10.1016/j.cmi.2018.05.010. Epub 2018 May 25.
8
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.绝对淋巴细胞计数：实体器官移植受者巨细胞病毒病复发的预测指标。
Clin Infect Dis. 2018 Oct 15;67(9):1395-1402. doi: 10.1093/cid/ciy295.
9
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study.丙型肝炎肝硬化导致肝移植受者巨细胞病毒再激活与更高的心血管风险相关——一项观察性、回顾性研究。
Transpl Int. 2018 Jun;31(6):649-657. doi: 10.1111/tri.13145. Epub 2018 Mar 26.
10
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.来特莫韦预防造血干细胞移植后巨细胞病毒感染。
N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.
Zotero 插件